Search Results - "Leimer, Maria"
-
1
Characterization of LDL and VLDL Binding Sites on Human Basophils and Mast Cells
Published in Arteriosclerosis, thrombosis, and vascular biology (01-01-1995)“…Recent data suggest that basophils and mast cells play a potential role in the processing and accumulation of plasma lipoproteins. This study investigated the…”
Get full text
Journal Article -
2
DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy
Published in Endocrinology (Philadelphia) (01-11-1999)“…Long acting somatostatin-14 (SST) analogs are used clinically to inhibit tumor growth and proliferation of various tumor types via binding to specific…”
Get full text
Journal Article -
3
Indium-111-DOTA-Lanreotide: Biodistribution, Safety and Radiation Absorbed Dose in Tumor Patients
Published in The Journal of nuclear medicine (1978) (01-11-1998)“…Imaging with radiolabeled somatostatin/vasoactive intestinal peptide analogs has recently been established for the localization diagnosis of a variety of human…”
Get full text
Journal Article -
4
Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET
Published in European journal of nuclear medicine and molecular imaging (01-10-2005)“…Radioiodine-negative thyroid cancer presents diagnostic and therapeutic difficulties, warranting the implementation of new imaging and treatment strategies…”
Get full text
Journal Article -
5
Response to Treatment with Yttrium 90-DOTA-Lanreotide of a Patient with Metastatic Gastrinoma
Published in The Journal of nuclear medicine (1978) (01-12-1998)“…1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid (DOTA)-lanreotide is a universal somatostatin (SST) receptor subtype ligand that binds to a large…”
Get full text
Journal Article -
6
Vasoactive Intestinal Peptide Receptor Scintigraphy
Published in The Journal of nuclear medicine (1978) (01-10-1995)“…This study presents the biodistribution, safety and absorbed dose of 123I-VIP administered to 18 patients with intestinal adenocarcinomas or endocrine tumors…”
Get full text
Journal Article -
7
Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells
Published in The Journal of experimental medicine (01-10-1996)“…Autonomous release of hematopoietic growth factors may play a crucial role in the pathogenesis of certain hematological malignancies. Because of its cytokine…”
Get full text
Journal Article -
8
Location of a VIPoma by Iodine-123-Vasoactive Intestinal Peptide Scintigraphy
Published in The Journal of nuclear medicine (1978) (01-09-1998)“…A major problem in patients with small endocrine tumors is the difficulty in localizing the primary tumor site. Many endocrine tumors possess larger amounts of…”
Get full text
Journal Article -
9
Value of Peptide Receptor Scintigraphy Using 123 I-Vasoactive Intestinal Peptide and 111 In-DTPA-D-Phe1-Octreotide in 194 Carcinoid Patients: Vienna University Experience, 1993 to 1998
Published in Journal of clinical oncology (13-03-2000)“…PURPOSE: To report our experience with both 123 I-vasoactive intestinal peptide (VIP) and 111 In-DTPA-D-Phe 1 -octreotide for imaging to identify primary and…”
Get full text
Journal Article -
10
Expression of Human Somatostatin Receptor Subtype 3 in Pancreatic Cancer In Vitro and In Vivo
Published in JNCI : Journal of the National Cancer Institute (04-11-1998)“…Raderer et al discuss the findings of their study on both the in vitro and in vivo expression of somatostatin receptors as judged by radioimaging of pancreatic…”
Get full text
Journal Article -
11
Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b : Pulmonary deposition and dose escalation study in healthy volunteers
Published in The Journal of nuclear medicine (1978) (01-09-1997)“…Recent studies have suggested that recombinant interferon gamma (IFNg) may be useful in the treatment of various respiratory diseases, such as chronic…”
Get full text
Journal Article -
12
DOTA-Lanreotide: A Novel Somatostatin Analog for Tumor Diagnosis and Therapy1
Published in Endocrinology (Philadelphia) (01-11-1999)“…Long acting somatostatin-14 (SST) analogs are used clinically to inhibit tumor growth and proliferation of various tumor types via binding to specific…”
Get full text
Journal Article -
13
Comparison of Iodine-123-Vasoactive Intestinal Peptide Receptor Scintigraphy and Indium-111-CYT- 103 Immunoscintigraphy
Published in The Journal of nuclear medicine (1978) (01-09-1996)“…Recently, we have shown that the expression of receptors for vasoactive intestinal peptide (VIP) on intestinal adenocarcinomas can be used for in vivo…”
Get full text
Journal Article -
14
-
15
-
16
Technetium-99m-Galactosyl-Neoglycoalbumin Combined with Iodine-123-Tyr-(A14)-Insulin Visualizes Human Hepatocellular Carcinomas
Published in The Journal of nuclear medicine (1978) (01-10-1995)“…Human hepatocellular carcinoma (HCC) is the most frequent primary hepatic malignancy and its diagnosis by conventional methods is still difficult. We…”
Get full text
Journal Article -
17
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829
Published in Cancer research (Chicago, Ill.) (01-05-1998)“…Recent data suggest that somatostatin receptors (SSTRs) are expressed on various tumor cells. High-level expression of SSTR on the tumor cell surface provides…”
Get full text
Journal Article -
18
-
19
Combined use of 111in-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC)
Published in Nuclear medicine and biology (01-05-1996)“…Although serum calcitonin and CEA are sensitive indicators for the presence of medullary thyroid carcinoma (MTC), the localization of tumor sites may be very…”
Get full text
Journal Article